Navigation Links
Nu-Tek BioSciences, LLC. Launches Animal-Free, Non-GM Soy Peptone
Date:12/16/2009

Nu-Tek BioSciences, LLC introduces HSP-A Soy Peptone. HSP A has been found to be effectinve in improving yelds of probiotic microorganisms.

(PRWEB) December 16, 2009 -- Nu-Tek BioSciences, LLC. (www.nu-tekproducts.com) is meeting the demand for Non-Animal Peptones by introducing HSP-A Soy Peptone. HSP-A, previously manufactured by Nutricepts, Inc. (Burnsville, Mn), is a high quality Soy Peptone. HSP-A is proven to improve growth rates and yields. HSP-A has been found to be especially effective in improving yields of the probiotic microorganisms L. acidophilus and Bifidobacterium ssp. Nu-Tek utilizes a unique proprietary process to enzymatically hydrolyze and purify soy protein to produce a high quality peptone. Only enzymes of microbial orgin are used to produce these peptones. HSP-A can be used in cell culture, microbiological media and fermentation media.

###

Read the full story at http://www.prweb.com/releases/2009/12/prweb3349904.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1

Related biology technology :

1. Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc.
2. Cryo-Cell Announces Strategic Partnership With S-Evans Biosciences, Inc.
3. LaVoie Group Selected by Vaccine Developer, Profectus BioSciences, as Agency of Record
4. Pressure BioSciences, Inc. Reports Record Revenue, Significantly Reduced Operating Loss for the Fourth Quarter of 2008
5. Pressure BioSciences, Inc. to Present at the EdgeWater Research Partners Spring 2009 Micro/Small-Cap Investor Conference
6. Pressure BioSciences, Inc. Announces Completion of Private Placement
7. Pressure BioSciences, Inc. and the J. Craig Venter Institute Announce Collaboration Agreement & Purchase of a PCT System
8. Abbott Exercises Its Option to Acquire Ibis Biosciences, a Subsidiary of Isis
9. Pressure BioSciences, Inc. and Omni International Announce Marketing, Distribution, and Technology Development Agreement
10. Pressure BioSciences, Inc. Provides Corporate Update
11. Pressure BioSciences, Inc. Announces Research Agreement With the US Army Medical Research Institute of Infectious Diseases (USAMRIID)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample tracking software company, ... Crime Laboratory, has joined STACS DNA as a Field Application Specialist. , “I ... President and COO of STACS DNA. “In further expanding our capacity as a scientific ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... 23, 2016 Andrew ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
Breaking Biology Technology:
(Date:6/3/2016)... , June 3, 2016 ... von Nepal hat ... Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung ... in der Produktion und Implementierung von Identitätsmanagementlösungen. ... Ausschreibung im Januar teilgenommen, aber Decatur wurde ...
(Date:6/1/2016)... NEW YORK , June 1, 2016 ... Biometric Technology in Election Administration and Criminal Identification to ... According to a recently released TechSci Research report, " ... Sector, By Region, Competition Forecast and Opportunities, 2011 - ... $ 24.8 billion by 2021, on account of growing ...
(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
Breaking Biology News(10 mins):